Drugs / Omicron-containing COVID-19 vaccine
Omicron-containing COVID-19 vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06091410 | Sep 2023 → Feb 2025 | COVID-19, influenza | Catholic Kwandong University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Omicron-containing COVID-19 vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06091410 ↗ |
| Modality | Messenger RNA (mRNA) | “omicron containing messenger ribonucleic acid (mRNA) COVID-19 booster” NCT06091410 ↗ |